Trial
NCT05253209
A Study Evaluating the Efficacy and Safety of IV L-Citrulline for the Prevention of Clinical Sequelae of Acute Lung Injury Induced by Cardiopulmonary Bypass in Pediatric Patients Undergoing Surgery for Congenital Heart Defects
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Asklepion Pharmaceuticals, LLC
Collaborators
—
Condition
Ventricular Septal Defect
Intervention
L-citrulline
Why stopped
Interim Analysis triggered futility
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-09-19